212 related articles for article (PubMed ID: 33672903)
1. Tannic Acid-Stabilized Silver Nanoparticles Used in Biomedical Application as an Effective Antimelioidosis and Prolonged Efflux Pump Inhibitor against Melioidosis Causative Pathogen.
Srichaiyapol O; Thammawithan S; Siritongsuk P; Nasompag S; Daduang S; Klaynongsruang S; Kulchat S; Patramanon R
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672903
[No Abstract] [Full Text] [Related]
2. Andrographolide stabilized-silver nanoparticles overcome ceftazidime-resistant Burkholderia pseudomallei: study of antimicrobial activity and mode of action.
Thammawithan S; Talodthaisong C; Srichaiyapol O; Patramanon R; Hutchison JA; Kulchat S
Sci Rep; 2022 Jun; 12(1):10701. PubMed ID: 35739211
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Clinical Isolates of
Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N
Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324
[No Abstract] [Full Text] [Related]
4. Two-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei.
Siritongsuk P; Hongsing N; Thammawithan S; Daduang S; Klaynongsruang S; Tuanyok A; Patramanon R
PLoS One; 2016; 11(12):e0168098. PubMed ID: 27977746
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
Sarovich DS; Price EP; Von Schulze AT; Cook JM; Mayo M; Watson LM; Richardson L; Seymour ML; Tuanyok A; Engelthaler DM; Pearson T; Peacock SJ; Currie BJ; Keim P; Wagner DM
PLoS One; 2012; 7(2):e30789. PubMed ID: 22363490
[TBL] [Abstract][Full Text] [Related]
6. Impact of nutritional stress on drug susceptibility and biofilm structures of Burkholderia pseudomallei and Burkholderia thailandensis grown in static and microfluidic systems.
Anutrakunchai C; Bolscher JGM; Krom BP; Kanthawong S; Chareonsudjai S; Taweechaisupapong S
PLoS One; 2018; 13(3):e0194946. PubMed ID: 29579106
[TBL] [Abstract][Full Text] [Related]
7. Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps.
Sirijant N; Sermswan RW; Wongratanacheewin S
J Med Microbiol; 2016 Nov; 65(11):1296-1306. PubMed ID: 27702426
[TBL] [Abstract][Full Text] [Related]
8. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
9. Drug susceptibility and biofilm formation of Burkholderia pseudomallei in nutrient-limited condition.
Anutrakunchai C; Sermswan RW; Wongratanacheewin S; Puknun A; Taweechaisupapong S
Trop Biomed; 2015 Jun; 32(2):300-9. PubMed ID: 26691259
[TBL] [Abstract][Full Text] [Related]
10. Silver Nanoparticles Enhance Antimicrobial Efficacy of Antibiotics and Restore That Efficacy against the Melioidosis Pathogen.
Malawong S; Thammawithan S; Sirithongsuk P; Daduang S; Klaynongsruang S; Wong PT; Patramanon R
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356761
[TBL] [Abstract][Full Text] [Related]
11. D-LL-31 in combination with ceftazidime synergistically enhances bactericidal activity and biofilm destruction in
Wongkaewkhiaw S; Taweechaisupapong S; Anutrakunchai C; Nazmi K; Bolscher JGM; Wongratanacheewin S; Kanthawong S
Biofouling; 2019 May; 35(5):573-584. PubMed ID: 31282211
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei.
Kanthawong S; Bolscher JG; Veerman EC; van Marle J; de Soet HJ; Nazmi K; Wongratanacheewin S; Taweechaisupapong S
Int J Antimicrob Agents; 2012 Jan; 39(1):39-44. PubMed ID: 22005071
[TBL] [Abstract][Full Text] [Related]
13. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
[TBL] [Abstract][Full Text] [Related]
14. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
Yuan YG; Peng QL; Gurunathan S
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
[TBL] [Abstract][Full Text] [Related]
15. Optical microscopy reveals the dynamic nature of B. pseudomallei morphology during β-lactam antimicrobial susceptibility testing.
McLaughlin HP; Bugrysheva J; Sue D
BMC Microbiol; 2020 Jul; 20(1):209. PubMed ID: 32677888
[TBL] [Abstract][Full Text] [Related]
16. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
[TBL] [Abstract][Full Text] [Related]
18. DNase I and chitosan enhance efficacy of ceftazidime to eradicate Burkholderia pseudomallei biofilm cells.
Pakkulnan R; Thonglao N; Chareonsudjai S
Sci Rep; 2023 Jan; 13(1):1059. PubMed ID: 36658182
[TBL] [Abstract][Full Text] [Related]
19. Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
Tribuddharat C; Moore RA; Baker P; Woods DE
Antimicrob Agents Chemother; 2003 Jul; 47(7):2082-7. PubMed ID: 12821450
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
